Terns Pharmaceuticals, Inc. — Director's Dealing 2026

Mar 17, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2026-03-16

Reporting Person: Burroughs Amy L. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-03-16	Common Stock	M	14583.00	$4.64	Acquired	303559.00	Direct
2026-03-16	Common Stock	S	11813.00	$46.5657	Disposed	291746.00	Direct
2026-03-16	Common Stock	S	2770.00	$47.3024	Disposed	288976.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-03-16	Stock Option (Right to Buy)	$4.64	M	14583.00	Disposed	2035-01-29	Common Stock (14583.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8319.00	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025.

F2: This sale price represents the weighted average sale price of the shares sold ranging from $46.01 to $47.005 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: This sale price represents the weighted average sale price of the shares sold ranging from $47.01 to $47.91 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: The Reporting Person beneficially owns these shares indirectly through the Amy L Burroughs 2017 Trust.

F5: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.